
Journal of the American Chemical Society p. 1800 - 1812 (1992)
Update date:2022-08-05
Topics:
Chu, Kent S.
Negrete, George R.
Konopebki, Joseph P.
Lakner, Frederick J.
Woo, Nam-Tae
Olmstead, Marilyn M.
We report herein full experimental details of the synthesis, structure, and reactivity of (R)- and (S)-2-tert-butyl-l-carbomethoxy-2,3-dihydropyrimidin-4(lH)-one (1). The synthesis employs asparagine as the starting material and provides 1 in 55% yield without the need for Chromatographic purification. The structure of 1, as determined by X-ray crystallographic analysis, demonstrates significant pyramidalization at the C4 (carbonyl) and N1 centers, with little evidence of conjugation of Nl with the αβ,-unsaturated (vinylogous urea) system. In contrast, compound 11 [2-tert-butyl-3-((S)-O-methylmandeloyl)-2,3-dihydropyrimidin-4(lH)-one] shows strong coupling of Nl to the αβ,-unsaturated system, as evidenced by changes in bond lengths and torsional angles. Compound 1 has proven useful as a reagent for the synthesis of enantiomerically pure β-aryl-β-amino acids. The key step in this protocol is the palladium-catalyzed conjugate addition of aryl iodides to 1. Evidence is presented to support a mechanism for this reaction that involves an unprecedented transannular hydride transfer into the palladium coordination sphere. In additional experiments, 1 has been employed as an auxiliary for the synthesis of enantiomerically pure α-substituted carboxylic acids. The crystalline properties of 1 and many of its derivatives allow for simplified purification procedures to be utilized.
View MoreSPRING CHEMICAL INDUSTRY CO.,LTD
Contact:86-187-66672125
Address:linchi industry park.zouping
Contact:+86-371-67759225
Address:No.32, Jinsuo Road, High-tech Zone
Zhuhai Rundu Pharmaceutical co.,Ltd
Contact:+86-756-7630755
Address:No.6,North Airport Road,Sanzao Town,Jinwan District
Contact:+44 7958 511245
Address:PO Box 469, Manchester, UK
HangZhou HuaYe Chemical Technology Co.,Ltd
Contact:+86-13505815007
Address:hangzhou
Doi:10.1002/cbdv.200800217
(2009)Doi:10.1016/j.cclet.2010.04.020
(2010)Doi:10.1021/ol101595u
(2010)Doi:10.1016/j.tetlet.2010.06.127
(2010)Doi:10.1021/om1006903
(2010)Doi:10.1021/acsmedchemlett.9b00440
(2020)